We are live on ! Find out more
TTP

TITAN PHARMACEUTICAL INC
TTP

Delisted

TTP was delisted on the 24th of December, 2008.

Back to rankings

3 hedge funds and large institutions have $161K invested in TITAN PHARMACEUTICAL INC in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

40% less capital invested

Capital invested by funds: $271K → $161K (-$109K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GS
Gagnon Securities
New York
-$63.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
GS
1
Gagnon Securities
New York
$155K -$63.4K -137,410 -29%
VIA
2
Vantage Investment Advisors
Pennsylvania
$6K – – –
ECM
3
Estabrook Capital Management
New York
$462 – – –

TTP Hedge Fund Activity: Q4 2014 in Review

3 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q4 2014, worth a combined $161K — down 40% from $271K a quarter earlier.

Fund positioning in TTP was balanced in Q4 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Gagnon Securities, cutting an estimated $63.4K.

  • 3 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $161K of TITAN PHARMACEUTICAL INC stock for Q4 2014, down 40% quarter-over-quarter.
  • 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q4 2014 and 0 closed out.
  • The largest TITAN PHARMACEUTICAL INC seller in Q4 2014 was Gagnon Securities, an estimated $63.4K sold.

Based on aggregated 13F filings for Q4 2014.